Home    About Us    Medic-All    Bio B2B    Hot Topic     Expo     Login | Join Now          
Bio B2BJHL Biotech, Inc. 〉Regulatory Affairs Service

Regulatory Affairs Service


Unique and strategic regulatory pathway to market for CDMO clients and pipeline biosimilars


Regulatory Submissions
We have an internationally experienced team to lead CMC regulatory submissions for clients with many successful IND/CTA filings globally. Our goal is to save our clients valuable time and costs by providing hassle-free communication/responses and a deep understanding of the requirements for all phases of regulatory and clinical development.

Regulatory Communication
Along with providing a well-versed Regulatory Submission service for our clients, we can support regional Health Authority consultations & strategic planning, initiate Pre-IND and Scientific Advisory Meetings, and provide written support for the CMC sections of all types of dossiers.

Regulatory Strategy
We have established a close working relationship with agencies in EU, US, Australia, China, India and other Asian countries, with proven success in receiving approvals for PK/PD Clinical Trial Applications AND leading Phase I to III Safety & Efficacy Clinical Trials.
People who like this also like
  • SNP Array for Prenatal Test (Genetic Testing)
  • pMDI and DPI CMO
  • Analytical Capability and Protein Characterization
  • Preeclampsia Risk Screening
  • CMC / CDMO (Contract Development and Manufacturing Organization)
  • cGMP Manufacturing Service
  • Sinphar Oncology Drug Center
  • Process Development Service
  • Pre-clinical Service...(more information)
  • Formulation Development Service